Current Drug Discovery News and Events

Current Drug Discovery News and Events, Drug Discovery News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Tool encoded in coronaviruses provides a potential target for COVID-19
Coronaviruses exploit our cells so they can make copies of themselves inside us. (2021-02-23)

ET phones home!
A team of researchers from the Hebrew University of Jerusalem has discovered the first evidence of radio flares emitted only long after a star is destroyed by a black hole. (2021-02-23)

NYUAD researchers develop high throughput paper-based arrays of 3D tumor models
By engineering common filter papers, similar to coffee filters, a team of NYU Abu Dhabi researchers have created high throughput arrays of miniaturized 3D tumor models to replicate key aspects of tumor physiology, which are absent in traditional drug testing platforms. With the new paper-based technology, the formed tumor models can be safely cryopreserved and stored for prolonged periods for on-demand drug testing use. (2021-02-22)

Direct cloning method CAPTUREs novel microbial natural products
Microorganisms possess natural product biosynthetic gene clusters (BGCs) that may harbor unique bioactivities for use in drug development and agricultural applications. However, many uncharacterized microbial BGCs remain inaccessible. Researchers at Illinois previously demonstrated a technique using transcription factor decoys to activate large, silent BGCs in bacteria to aid in natural product discovery. (2021-02-19)

Insilico announces MolGrow -- a new generative model for hierarchical molecular generation
Insilico Presented Its New Molecular Generation Model at the 35th AAAI Conference on Artificial Intelligence (2021-02-11)

The therapeutic potential of peptides
There are more than 80 peptide drugs on the global market and about twice as many in clinical development. Due to their beneficial properties, these biomolecules play already an important role in the treatment of diseases. In Nature Reviews Drug Discovery, a team of Austrian and Australian scientists led by Markus Muttenthaler of the University of Vienna present an outlook on the latest trends in peptide drug discovery and development. (2021-02-10)

Use of goldenseal may compromise glucose control in diabetics on metformin
Diabetic patients taking the natural product goldenseal while taking the prescription drug metformin may be unwittingly sabotaging their efforts to maintain healthy blood glucose levels. Metformin--the world's most-prescribed oral glucose-lowering medication--was included in a cocktail of selected drugs given to participants in a clinical study led by scientists at Washington State University. The study found that after six days of taking goldenseal, participants had about 25 percent less metformin in their bodies. (2021-02-08)

Researchers develop platform to identify cancer mutations that may be responsive to drug therapies
A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate genomic medicine research and genome-informed drug discovery, according to new study results published recently in Genome Biology. (2021-02-08)

Ground-breaking evidence reveals scalp cooling physically protects hair follicles
GROUND-BREAKING research from the University of Huddersfield, announced ahead of World Cancer Day 2021, proves that scalp cooling physically protects hair follicles from chemotherapy drugs. It is the world's first piece of biological evidence that explains how scalp cooling actually works and the mechanism behind its protection of the hair follicle. (2021-02-03)

Cancer research expands body's own immune system to kill tumors
Scientists are hoping advances in cancer research could lead to a day when a patient's own immune system could be used to fight and destroy a wide range of tumors. Cancer immunotherapy has some remarkable successes, but its effectiveness has been limited to a relatively small handful of cancers. In APL Bioengineering, researchers describe how advances in engineering models of tumors can greatly expand cancer immunotherapy's effectiveness to a wider range of cancers. (2021-02-02)

BU researchers identify promising therapeutic agent against melanoma
There have been great advances in treating melanoma over the past five years, however, even with these treatments many patients quickly develop drug resistance and die from their disease. A new study from Boston University School of Medicine (BUSM) has discovered that a drug (YK-4-279) that was previously created to target one specific type of protein has much broader use against a family of proteins that act to promote melanoma. (2021-02-01)

February special issue of SLAS Discovery focuses on hit discovery methodologies
The February edition of SLAS Discovery is a Special Issue on Hit Discovery Methodologies edited by Mark Wigglesworth, Ph.D., (Medicines Discovery Catapult, Stockport, EN, UK) and Peter Hodder, Ph.D. (Amgen, Thousand Oaks, CA, USA). (2021-02-01)

SLAS Technology special collection on AI in process automation available now
The February edition of SLAS Technology is a special collection of articles focused on 'Artificial Intelligence in Process Automation' by Guest Editor Cenk Ündey, Ph.D. (Amgen, Thousand Oaks, CA, USA). (2021-02-01)

Novel therapy-resistance mechanism promoting the growth of breast cancer brain metastasis
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska's research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing SORLA from cancer cells sensitized anti-HER2 resistant breast cancer brain metastasis to targeted therapy. (2021-01-29)

Accurate drug dosages with proton traps
Researchers at Linköping University, Sweden, have developed a proton trap that makes organic electronic ion pumps more precise when delivering drugs. The new technique may reduce drug side effects, and in the long term, ion pumps may help patients with symptoms of neurological diseases for which effective treatments are not available. The results have been published in Science Advances. (2021-01-29)

Pharmaceutical research: when active substance and target protein 'embrace' each other
Scientists at Goethe University Frankfurt, together with colleagues from Darmstadt, Heidelberg, Oxford and Dundee (UK), have investigated how the fit of potent inhibitors to their binding sites can be optimised so that they engage longer with their target proteins. Long target residency has been associated with more efficient pharmacological responses e.g. in cancer therapy. In future, the researchers want to use computer simulations to predict the residence time of inhibitors during drug development. (2021-01-28)

New Tel Aviv University study reveals 'Achilles' heel' of cancer cells
A new study from Tel Aviv University (TAU) shows, for the first time, how an abnormal number of chromosomes (aneuploidy) -- a unique characteristic of cancer cells that researchers have known about for decades -- could become a weak point for these cells. The study could lead to the development of future drugs that will use this vulnerability to eliminate the cancer cells. (2021-01-27)

Gut microbiota reveals whether drug therapies work in inflammatory bowel diseases
A study recently completed at the University of Helsinki indicates that the gut microbiota of patients suffering from inflammatory gastrointestinal disorders can be used to predict whether they will benefit from expensive therapies. The study also confirms the key role of therapies that have a beneficial effect on the gut microbiota in inflammatory bowel diseases. (2021-01-26)

University of Cincinnati research unveils possible new combo therapy for head and neck cancer
Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better. Since they're using a Food and Drug Administration-approved drug to do it, this could help people sooner than later. (2021-01-22)

Unlocking 'the shape of water' in mechanisms of antibiotic resistance
Researchers captured and comparted hi-res images of ribosome structures from sensitive and resistant bacteria and report that a water molecule needed for antibiotic binding was not present in the ribosomes from the drug-resistant bugs. (2021-01-19)

Study suggests compound protects myelin, nerve fibers
A compound developed at Oregon Health & Science University appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord. The new research in a mouse model advances earlier work to develop the compound - known as sobetirome - that has already showed promise in stimulating the repair of myelin. (2021-01-13)

Endocrine Society recommends government negotiation and other policies to lower out-of-pocket costs
The Endocrine Society is calling on policymakers to include government negotiation as part of an overall strategy to reduce insulin prices in its updated position statement published today in The Journal of Clinical Endocrinology & Metabolism. (2021-01-12)

New drug form may help treat osteoporosis, calcium-related disorders
Purdue University innovators developed a stabilized form of human calcitonin, which is a peptide drug already used for people with osteoporosis. Researchers at Purdue created a prodrug form of the peptide hormone to increase its effectiveness as an osteoporosis treatment. (2021-01-06)

ADDF presents vision of a consortium to accelerate research into speech and language biomarkers for Alzheimer's disease
In a commentary in Exploration in Medicine, Alzheimer's experts lay out a vision for a worldwide research consortium that can give clinicians -- and patients -- the answers to which speech and language changes may signal Alzheimer's in the form of digital biomarkers. (2021-01-05)

UC researcher urges caution using remdesivir to treat COVID-19
Research at the University of Cincinnati, however, contends that this antiviral drug is being used too indiscriminately when treating patients hospitalized with the virus. The study is published in the journal Fundamental & Clinical Pharmacology. (2020-12-29)

HKU chemists develop a new drug discovery strategy for "undruggable" drug targets
A research team led by Dr Xiaoyu LI from the Research Division for Chemistry, Faculty of Science, in collaboration with Professor Yizhou LI from School of Pharmaceutical Sciences, Chongqing University and Professor Yan CAO from School of Pharmacy, Second Military Medical University in Shanghai has developed a new drug discovery method targeting membrane proteins on live cells. (2020-12-28)

New drug inhibits the growth of cancer cells
Blocking gene expression in mitochondria in mice stops cancer cells from growing (2020-12-22)

Sex-specific Alzheimer's treatment could benefit males over females
A University of Ottawa study found a specific Alzheimer's treatment is effective in male and not female mice, providing a window into the biology of the disease and the effectiveness of targeted treatments. (2020-12-21)

January issue of SLAS Discovery "Cryo-EM: The Resolution Revolution and Drug Discovery"
The January edition of SLAS Discovery features the cover article, ''Cryo-EM: The Resolution Revolution and Drug Discovery'' by Taiana Maia de Oliveira, Ph.D., Lotte van Beek, Ph.D., Fiona Shilliday, Ph.D., Judit E. Debreczeni, Ph.D., and Chris Phillips, Ph.D., from AstraZeneca. (2020-12-21)

Scientists discover a new type of brain cell that could help detect distance
A new kind of brain cell has been discovered which will help to understand how we remember where we left objects, such as car keys and mobile phones. (2020-12-21)

Three-dimensionally reconstituted organoids that are just like human organs
POSTECH-Seoul National University Hospital research team publishes the new concept of assembloids in Nature. (2020-12-18)

New recipe for antibiotic could prevent deafness
Stanford Medicine scientists have discovered a simple method of reformulating gentamicin, a commonly used and highly effective antibiotic, that could prevent its toxic side effect of hearing loss. (2020-12-16)

Undruggable diseases gain a new RNA drug-discovery tool
A new RNA-targeting tool enables scientists to tackle difficult molecular recognition problems to aid drug discovery for incurable diseases. (2020-12-15)

Genes could be key to new COVID-19 treatments, study finds
Potential treatments for Covid-19 have been identified after the discovery of five genes associated with the most severe form of the disease. (2020-12-11)

NUS researchers finds best combination of available therapies against COVID-19
Researchers from the National University of Singapore have utilised a ground-breaking AI platform to find an optimal combination of available therapies against COVID-19. The research team identified the drug combination from over 530,000 possibilities within two weeks, cutting down the number of tests typically needed by hundreds of thousands. (2020-12-10)

Using targeted microbubbles to administer toxic cancer drugs
New research has shown how microbubbles carrying powerful cancer drugs can be guided to the site of a tumour using antibodies. Microbubbles are small manufactured spheres half the size of a red blood cell - and scientists believe they can be used to transport drugs to highly specific locations within the body. (2020-12-08)

Potential cancer therapy may boost immune response
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according to a study led by Cedars-Sinai Cancer investigators. (2020-12-07)

Drug for rare disorder shows promise for treating herpes viruses
New research shows that the antiviral activity of the drug -- called phenylbutyrate, or PBA -- was even better when used along with acyclovir, a common HSV-1 treatment. When used in combination, less acyclovir is needed to effectively suppress the virus compared to acyclovir alone -- this is important because acyclovir is also known to have toxic side effects in the kidneys. (2020-12-07)

Protein molecules in cells function as miniature antennas
Researchers led by Josef Lazar from IOCB Prague have demonstrated that molecules of fluorescent proteins act as antennas with optical properties (i.e. the ability to absorb and emit light) dependent on their spatial orientation. First discovered in jellyfish, fluorescent proteins are nowadays widely used in studies of molecular processes in living cells and organisms. The newly described properties of these molecules will find applications in basic biological research as well as in novel drug discovery. (2020-12-02)

Imagining perfect molecules using AI - a benchmarking system for generative chemistry
Insilico Medicine together with collaborators announces the publication of Molecular Sets (MOSES), a benchmarking system for generative chemistry models. (2020-11-30)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.